VioQuest Pharmaceuticals, Inc.
VOQP · OTC
6/30/2008 | 3/31/2008 | 12/31/2007 | 9/30/2007 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 3.36 | -4.77 | -0.07 |
| FCF Yield | -90.02% | -30.88% | -36.80% | -19.03% |
| EV / EBITDA | -0.88 | -1.88 | -6.72 | -6.60 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.84 | 0.34 | 0.58 | 0.91 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -45.74% | 39.82% | 32.99% | -161.83% |
| Safety | ||||
| Net Debt / EBITDA | 0.79 | 0.18 | -2.14 | -0.04 |
| Interest Coverage | 9.97 | 1.18 | 4.29 | 4.93 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |